FDA Investigator Grace E Mcnally
Grace E Mcnally has inspections in 8 countries as of 02 Jun 2023. Grace E Mcnally has collaborated with a combinined 3426 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
55
Last Inspection Date:
02 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
China,
United States of America,
United Kingdom of Great Britain and Northern Ireland,
India,
Spain,
Canada,
Germany,
Netherlands
Co-Investigator(s):
A Williams,
Ademola O Daramola,
Alan P Kurtzberg,
Alanna Lmussawwir Bias,
Althea A Williams,
Amanda S Zorn,
Andrea A Branche,
Angelica G Aziz,
Anita Narula, PhD,
Ann Marie Montemurro,
Anthony J Lagreca,
Ashleigh P Barkans,
Ashleigh P Wodushek,
Azza Talaat,
Betty K Baxter,
Bryan A Galvez,
Bryan J Love,
Bryce A Hammer,
Carla A Norris,
Caroline H Le,
Chani Broner, PhD,
Charisse K Green,
Charles R Cote, RIC,
Christine I Shaw,
Christine W Twohy,
Cody D Rickman,
Cynthia Jim, CSO,
Cynthia T Cain,
Daniel J Grabicki,
Daniel J Lahar,
Daniel J Roberts,
Daniel Pst Laurent,
David J Gomes,
Deborah A Greco,
Debra I Love,
Debra L Curtis,
Dr. Barbara D Paul, PhD,
Dr. Robert C Horan, MD,
Edith M Gonzalez,
Eileen T Dupont,
Eric S Myskowski,
Erik W Burrows,
Erika V Butler,
Esther C Broner, PhD,
Farhana Khan,
Felix Maldonado,
Frank Verni,
Frederic W French, III,
Gary C Pecic,
George G Calafactor,
George J Flynn,
Gerard T Schneider,
Ginger M Sykes,
Grace E Mcnelly,
Grace E Menally,
Gwyn G Dickinson,
Hanna L Potter,
Haroon Vohra (NMI),
Harperd,
Isabel Y Espinosa,
Ismael Olvera, IV,
Jacqueline Mdiaz Albertini,
Jacqueline S Warner,
Jai P Singh,
James L Dannie, Jr,
James L Dunnie, Jr,
James M Odonnell,
James R Montero,
James W Plucinski,
Jamie L Dion,
Janet Pulver,
Jessie E Morris,
Jianming Li,
Joey V Quitania,
Jose Alopez Rubet,
Jose R Hernandez,
Joseph R Strelnik,
Juan A Morales,
Junho Pak,
Justin R Carr,
Kalavati Suvarna, PhD,
Karen G Hirshfield,
Katherine Szestypalow,
Kathleen S Tormey,
Kathryn M Mogen,
Kelly D Moore,
Kenneth H Williams,
Kenneth V Miller,
Kent C Faul,
Kevin A Gonzalez,
Kevin D Kallander,
Kham Phommachanh,
Khumo A Phake,
Kimberley A Hoefen,
Kimetha A King,
Kristen E Szenderski,
Larisa E Pavlick,
Larry K Austin,
Laura B Kennedy,
Lavender M Huskey,
Lewis K Antwi,
Linda M Cheny,
Lori A Carr,
Luis A Dasta,
Lydia Irosas Marty,
Lydia Trosas Marty,
Manuel A Moreno,
Marc A Jackson, Jr,
Marie Bbuen Bigornia,
Marie F Morin,
Marijo B Kambere, PhD,
Marion W Nadeau,
Mariza M Jafary,
Marlene G Swider,
Marsha L Mccauley,
Martina E Lagrange,
Matthew J Hansen,
Matthew M Vernon,
Matthew R Dionne,
Meyer J Slobotsky,
Michael A Charles,
Michael E Maselli,
Michael J Kuchta,
Michael R Goga,
Michael S Araneta,
Michele L Obert,
Mihaly S Ligmond,
Minh D Phan,
Muralidhara B Gavini, PhD,
Nancy G Schmidt,
Nancy L Neiger,
Nathan M Jornod,
Nathan R Moon,
Nayan J Patel,
Nicholas R Nance,
Oluwaseyi Ojinni,
Omotunde O Osunsanmi,
Parul M Patel,
Patricia A Brown,
Patricia A Cortez,
Patricia A Maestas,
Paul J Teitell,
Paul Z Balcer,
Paula A Trost,
Peter E Baker,
Philip E Ake,
Prabhu P Raju,
Reba A Gates,
Regina T Brown,
Richard Jay Tucker, RS,
Richard L Rutherford,
Ricki A Chase,
Ricki Achase Off,
Robert D Tollefsen,
Robert J Doyle,
Rochelle L Cross,
Roger F Zabinski,
Roger L Farmer,
Ronda R Loyd Jones,
Rose M Ashley,
Santiago Gallardo Johnson,
Scott R Izyk,
Scott T Panagiotis,
Sheila Alaghemand,
Shererk,
Sidney B Priesmeyer,
State Agency,
Stephen D Brown,
Stephen D Eich,
Steve P Yost,
Steve Y Rhieu, PhD,
Steven C Madzo,
Steven O Gauthier,
Susan M Jackson,
Susan W Ting,
Tamil Arasu, PhD,
Tara L Breckenridge,
Tara L Greene,
Thai T Duong,
Theressa B Smith,
Thomas S Savage,
Thomas V Anderson,
Torrance J Slayton,
Unnee Ranjan,
Verlinda A Narcisse,
Vicky L Cruz,
Wanda B Coats,
Wayne W Grundstrom,
Wdouglas Rowe,
William A Warnick,
Yasamin Ameri,
Zachary A Bogorad,
Zachary L Miller,
Zachary L Stamm,
Zhong Li, PhD
Grace E Mcnally's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2000 | FDA 483 | IDEMSA - Form 483, 2000-10-05 |
September, 2008 | EIR | XIAN LIJUN PHARMACEUTICAL CO., LTD. - EIR, 2011-08-11 |
October, 2003 | FDA 483 Response | Cirrus Laboratories - Form 483R, 2003-11-24 |
December, 2001 | FDA 483 | Nelson Laboratories, LLC - Form 483, 2001-12-19 |
March, 2002 | FDA 483 | MedMira Laboratories Inc. - Form 483, 2002-03-27 |
January, 2000 | FDA 483 | Medical Systems of Denver, Inc. - Form 483, 2000-01-18 |
October, 2000 | EIR | IDEMSA - EIR, 2000-10-05 |
October, 2003 | EIR | CP Pharmaceuticals Ltd - EIR, 2003-12-10 |
September, 2008 | FDA 483 | XIAN LIJUN PHARMACEUTICAL CO., LTD. - Form 483, 2008-09-19 |
December, 2001 | EIR | Nelson Laboratories, LLC - EIR, 2001-12-19 |
October, 2003 | EIR | Cirrus Laboratories - EIR, 2003-11-14 |
October, 2003 | FDA 483 Response | CP Pharmaceuticals Ltd - Form 483R, 2004-01-08 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more